51 In the index

Brivaracetam BRIV

An FDA-approved anti-seizure medication used alongside other treatments for epilepsy. Human trials confirm it works well and tends to cause less irritability than a similar older drug.

Also known as Briviact

Effects Focus

Routes Oral

Legal status Prescription drug

WADA Not listed

3D Molecular Structure of C₁₁H₂₀N₂O₂

Drag to rotate · scroll to zoom

Chemistry

Formula: C11H20N2O2
Molar mass: 212.29
CAS: 357336-20-0
PubChem CID: 9837243

Reported dosing

Approved label

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 50-100 mg/day

Reported range 25-200 mg/day

Route Oral or IV

Frequency Twice daily

Duration Chronic/ongoing (as prescribed)

FDA-approved prescription antiepileptic (Briviact); a Schedule V controlled substance in the US.

Where this comes from FDA prescribing information

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.